MARKET

ABBV

ABBV

AbbVie
NYSE

Real-time Quotes | Nasdaq Last Sale

136.78
+0.91
+0.67%
After Hours: 136.77 -0.01 -0.01% 18:54 01/18 EST
OPEN
135.51
PREV CLOSE
135.87
HIGH
137.98
LOW
135.28
VOLUME
12.34M
TURNOVER
--
52 WEEK HIGH
138.15
52 WEEK LOW
101.81
MARKET CAP
241.81B
P/E (TTM)
32.56
1D
5D
1M
3M
1Y
5Y
Townsend & Associates, Inc Buys The AES Corp, ConocoPhillips, Huntsman Corp, Sells ...
Investment company Townsend & Associates, Inc (Current Portfolio) buys The AES Corp, ConocoPhillips, Huntsman Corp, Gilead Sciences Inc, AbbVie Inc, sells PowerShares QQQ Trust Ser 1, Morgan Stanley, Intuitive Surgical Inc, Apollo Global Management Inc, Un...
GuruFocus.com · 5h ago
HealthInvest Partners AB Buys McKesson Corp, Cardinal Health Inc, AmerisourceBergen Corp, Sells ...
Stockholm, V7, based Investment company HealthInvest Partners AB (Current Portfolio) buys McKesson Corp, Cardinal Health Inc, AmerisourceBergen Corp, Bristol-Myers Squibb Co, AbbVie Inc, sells Supernus Pharmaceuticals Inc, Accuray Inc, Aldeyra Therapeutics...
GuruFocus.com · 9h ago
Private Wealth Group, LLC Buys SPDR Bloomberg 1-10 Year TIPS ETF, AbbVie Inc, Sells SPDR ...
Investment company Private Wealth Group, LLC (Current Portfolio) buys SPDR Bloomberg 1-10 Year TIPS ETF, AbbVie Inc, sells SPDR Portfolio Intermediate Term Treasury ETF, iShares Core S&P Mid-Cap ETF, iShares Russell 2000 ETF, Health Care Select Sector SPDR...
GuruFocus.com · 9h ago
Sema4 Strengthens AI-Driven Genomic, Clinical Data Platform With $623M GeneDx Acquisition
View more earnings on SMFRSee more from BenzingaPfizer To Boost Output For COVID-19 Oral Treatment With Novasep DealFDA Gives Back To Back Approval To Pfizer's & AbbVie's JAK Inhibitors For Atopic Dermatitis© 2022 Benzinga.com. Benzinga does not provide in...
Benzinga · 13h ago
Zacks Industry Outlook Highlights: Roche, Pfizer, AbbVie and Merck
Roche, Pfizer, AbbVie and Merck are highlighted in this Industry Outlook article.
Zacks · 16h ago
FDA Gives Back To Back Approval To Pfizer's & AbbVie's JAK Inhibitors For Atopic Dermatitis
Along with AbbVie Inc's (NYSE: ABBV) 
Benzinga · 17h ago
FDA Approves AbbVie's Upadacitinib For Refractory Atopic Dermatitis In Patients 12 Years & Older
The 
Benzinga · 18h ago
AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know
In the latest trading session, AbbVie (ABBV) closed at $135.87, marking a +1.76% move from the previous day.
Zacks · 1d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ABBV. Analyze the recent business situations of AbbVie through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 26 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

19.23%Strong Buy
61.54%Buy
19.23%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average ABBV stock price target is 138.26 with a high estimate of 172.00 and a low estimate of 105.00.
High172.00
Average138.26
Low105.00
Current 136.78
EPS
Actual
Estimate
0.831.672.503.33
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Institutional Holdings
Institutions: 3.36K
Institutional Holdings: 1.27B
% Owned: 72.01%
Shares Outstanding: 1.77B
TypeInstitutionsShares
Increased
1.30K
53.43M
New
104
3.33M
Decreased
863
55.91M
Sold Out
94
4.96M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
-0.21%
Pharmaceuticals & Medical Research
-1.37%
Key Executives
Chairman/Chief Executive Officer/Director
Richard Gonzalez
President/Vice Chairman - Management
Michael Severino
Vice Chairman/Chief Financial Officer/Director
Robert Michael
Vice Chairman - Management
Laura Schumacher
Chief Human Resource Officer/Executive Vice President
Timothy Richmond
Executive Vice President
Henry Gosebruch
Executive Vice President
Azita Saleki - Gerhardt
Senior Vice President
Thomas Hudson
Senior Vice President
Elaine Sorg
Senior Vice President
Jeffrey Stewart
Senior Vice President
Carrie Strom
Vice President/Controller
Brian Durkin
Lead Director/Independent Director
Glenn Tilton
Independent Director
Robert Alpern
Independent Director
Roxanne Austin
Independent Director
William Burnside
Independent Director
Thomas Freyman
Independent Director
Brett Hart
Independent Director
Edward Liddy
Independent Director
Melody Meyer
Independent Director
Edward Rapp
Independent Director
Rebecca Roberts
Independent Director
Frederick Waddell
Declaration Date
Dividend Per Share
Ex-Div Date
--
Dividend USD 1.41
01/13/2022
--
Dividend USD 1.3
10/14/2021
06/17/2021
Dividend USD 1.3
07/14/2021
02/18/2021
Dividend USD 1.3
04/14/2021
10/30/2020
Dividend USD 1.3
01/14/2021
09/11/2020
Dividend USD 1.18
10/14/2020
06/17/2020
Dividend USD 1.18
07/14/2020
02/20/2020
Dividend USD 1.18
04/14/2020
11/01/2019
Dividend USD 1.18
01/14/2020
09/06/2019
Dividend USD 1.07
10/11/2019
06/20/2019
Dividend USD 1.07
07/12/2019
02/21/2019
Dividend USD 1.07
04/12/2019
11/02/2018
Dividend USD 1.07
01/14/2019
09/07/2018
Dividend USD 0.96
10/12/2018
06/14/2018
Dividend USD 0.96
07/12/2018
02/15/2018
Dividend USD 0.96
04/12/2018
10/26/2017
Dividend USD 0.71
01/11/2018
09/08/2017
Dividend USD 0.64
10/12/2017
06/23/2017
Dividend USD 0.64
07/12/2017
02/17/2017
Dividend USD 0.64
04/11/2017
About ABBV
AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. AbbVie offers its products in various therapeutic categories, including Immunology products, which include Humira, Skyrizi and Rinvoq; Oncology products consists of Imbruvica and Venclexta; Aesthetics products include Botox Cosmetic, Juvederm Collection and other aesthetics; Neuroscience products, such as Botox Therapeutic, Vraylar, Duopa and Duodopa, and Ubrelvy; Eye care products consists of Lumigan, Alphagan and Restasis ; Women's health products incudes Lo Loestrin, Orilissa and other women's health; and Other key products, which includes Mavyret, Creon, Lupron, Linzess and Synthroid. The Company's products are sold worldwide directly to wholesalers, distributors, government agencies, health care facilities and independent retailers from AbbVie-owned distribution centers and public warehouses.

Webull offers kinds of AbbVie Inc stock information, including NYSE:ABBV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ABBV stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ABBV stock methods without spending real money on the virtual paper trading platform.